The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Noncanonical Wnt Signaling Promotes Obesity-Induced Adipose Tissue Inflammation and Metabolic Dysfunction Independent of Adipose Tissue Expansion
Open accessAbstract
Adipose tissue dysfunction plays a pivotal role in the development of insulin resistance in obese individuals. Cell culture studies and gain-of-function mouse models suggest that canonical Wnt proteins modulate adipose tissue expansion. However, no genetic evidence supports a role for endogenous Wnt proteins in adipose tissue dysfunction, and the role of noncanonical Wnt signaling remains largely unexplored. Here we provide evidence from human, mouse, and cell culture studies showing that Wnt5a-mediated, noncanonical Wnt signaling contributes to obesity-associated metabolic dysfunction by increasing adipose tissue inflammation. Wnt5a expression is significantly upregulated in human visceral fat compared with subcutaneous fat in obese individuals. In obese mice, Wnt5a ablation ameliorates insulin resistance, in parallel with reductions in adipose tissue inflammation. Conversely, Wnt5a overexpression in myeloid cells augments adipose tissue inflammation and leads to greater impairments in glucose homeostasis. Wnt5a ablation or overexpression did not affect fat mass or adipocyte size. Mechanistically, Wnt5a promotes the expression of proinflammatory cytokines by macrophages in a Jun NH2-terminal kinase–dependent manner, leading to defective insulin signaling in adipocytes. Exogenous interleukin-6 administration restores insulin resistance in obese Wnt5a-deficient mice, suggesting a central role for this cytokine in Wnt5a-mediated metabolic dysfunction. Taken together, these results demonstrate that noncanonical Wnt signaling contributes to obesity-induced insulin resistance independent of adipose tissue expansion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
Developmental Origin of Fat: Tracking Obesity to Its Source
Gesta, S., Tseng, Y.-H., & Kahn, C. R. (2007) · Cell · doi:10.1016/j.cell.2007.10.004 · Cited by 1,508 · cited 1×
“This has led to the hypothesis that the different developmental origins of the various fat depots contribute to its physiological, cellular, and molecular heterogeneity (16).”
BackgroundInterleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213
Suganami, T., Nishida, J., & Ogawa, Y. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000183883.72263.13 · Cited by 1,056
Klöting, N., Fasshauer, M., Dietrich, A., Kovacs, P., Schön, M. R., Kern, M., Stumvoll, M., & Blüher, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00586.2009 · Cited by 856
Mauer, J., Chaurasia, B., Goldau, J., Vogt, M. C., Ruud, J., Nguyen, K. D., Theurich, S., Hausen, A. C., Schmitz, J., Brönneke, H. S., et al. (2014) · Nature Immunology · doi:10.1038/ni.2865 · Cited by 727
The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals
Blüher, M. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283346ccc · Cited by 632
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J. Y., Ko, H. J., Barrett, T., Kim, J. K., & Davis, R. J. (2008) · Science · doi:10.1126/science.1160794 · Cited by 604
Maeda, K., Kobayashi, Y., Udagawa, N., Uehara, S., Ishihara, A., Mizoguchi, T., Kikuchi, Y., Takada, I., Kato, S., Kani, S., et al. (2012) · Nature Medicine · doi:10.1038/nm.2653 · Cited by 542
Solinas, G., Vilcu, C., Neels, J. G., Bandyopadhyay, G. K., Luo, J.-L., Naugler, W., Grivennikov, S., Wynshaw-Boris, A., Scadeng, M., Olefsky, J. M., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.011 · Cited by 513
Chronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Klover, P. J., Zimmers, T. A., Koniaris, L. G., & Mooney, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2784 · Cited by 488
Lumeng, C. N., Deyoung, S. M., & Saltiel, A. R. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00284.2006 · Cited by 359
Research works printed but not linked: 67
- Neeland, 2012, Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults, JAMA, 308, 1150, 10.1001/2012.jama.11132 · DOI · Paper page
- Boyko, 2000, Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans, Diabetes Care, 23, 465, 10.2337/diacare.23.4.465 · DOI · Paper page
- Preis, 2010, Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study, Obesity (Silver Spring), 18, 2191, 10.1038/oby.2010.59 · DOI · Paper page
- McLaughlin, 2011, Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity, J Clin Endocrinol Metab, 96, E1756, 10.1210/jc.2011-0615 · DOI · Paper page
- Porter, 2009, Abdominal subcutaneous adipose tissue: a protective fat depot?, Diabetes Care, 32, 1068, 10.2337/dc08-2280 · DOI · Paper page
- Snijder, 2005, Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study, Diabetologia, 48, 301, 10.1007/s00125-004-1637-7 · DOI · Paper page
- Farb, 2012, Arteriolar function in visceral adipose tissue is impaired in human obesity, Arterioscler Thromb Vasc Biol, 32, 467, 10.1161/ATVBAHA.111.235846 · DOI
- Adams, 1997, Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation, J Clin Invest, 100, 3149, 10.1172/JCI119870 · DOI · Paper page
- Tchkonia, 2002, Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes, Am J Physiol Regul Integr Comp Physiol, 282, R1286, 10.1152/ajpregu.00653.2001 · DOI · Paper page
- Tchkonia, 2006, Fat depot-specific characteristics are retained in strains derived from single human preadipocytes, Diabetes, 55, 2571, 10.2337/db06-0540 · DOI · Paper page
- Gesta, 2006, Evidence for a role of developmental genes in the origin of obesity and body fat distribution, Proc Natl Acad Sci U S A, 103, 6676, 10.1073/pnas.0601752103 · DOI · Paper page
- Yamamoto, 2010, Adipose depots possess unique developmental gene signatures, Obesity (Silver Spring), 18, 872, 10.1038/oby.2009.512 · DOI · Paper page
- Vohl, 2004, A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men, Obes Res, 12, 1217, 10.1038/oby.2004.153 · DOI · Paper page
- Logan, 2004, The Wnt signaling pathway in development and disease, Annu Rev Cell Dev Biol, 20, 781, 10.1146/annurev.cellbio.20.010403.113126 · DOI · Paper page
- Christodoulides, 2009, Adipogenesis and WNT signalling, Trends Endocrinol Metab, 20, 16, 10.1016/j.tem.2008.09.002 · DOI · Paper page
- Bennett, 2002, Regulation of Wnt signaling during adipogenesis, J Biol Chem, 277, 30998, 10.1074/jbc.M204527200 · DOI · Paper page
- Ross, 2000, Inhibition of adipogenesis by Wnt signaling, Science, 289, 950, 10.1126/science.289.5481.950 · DOI · Paper page
- Cawthorn, 2012, Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a β-catenin-dependent mechanism, Bone, 50, 477, 10.1016/j.bone.2011.08.010 · DOI · Paper page
- Wright, 2007, Wnt10b inhibits obesity in ob/ob and agouti mice, Diabetes, 56, 295, 10.2337/db06-1339 · DOI · Paper page
- Longo, 2004, Wnt10b inhibits development of white and brown adipose tissues, J Biol Chem, 279, 35503, 10.1074/jbc.M402937200 · DOI · Paper page
- Halleskog, 2012, Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformation, J Neuroinflammation, 9, 111, 10.1186/1742-2094-9-111 · DOI
- Blumenthal, 2006, The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation, Blood, 108, 965, 10.1182/blood-2005-12-5046 · DOI · Paper page
- Rauner, 2012, WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production, J Bone Miner Res, 27, 575, 10.1002/jbmr.1488 · DOI
- Pereira, 2008, Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10, Arterioscler Thromb Vasc Biol, 28, 504, 10.1161/ATVBAHA.107.157438 · DOI · Paper page
- Pukrop, 2006, Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines, Proc Natl Acad Sci U S A, 103, 5454, 10.1073/pnas.0509703103 · DOI · Paper page
- Miyoshi, 2012, Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury, Science, 338, 108, 10.1126/science.1223821 · DOI · Paper page
- Yamaguchi, 1999, A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo, Development, 126, 1211, 10.1242/dev.126.6.1211 · DOI · Paper page
- Zhao, 2013, SFRP5 inhibits gastric epithelial cell migration induced by macrophage-derived Wnt5a, Carcinogenesis, 34, 146, 10.1093/carcin/bgs309 · DOI
- Bilkovski, 2011, Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans, Int J Obes (Lond), 35, 1450, 10.1038/ijo.2011.6 · DOI
- Katoh, 2009, Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades, Int J Mol Med, 23, 763, 10.3892/ijmm_00000190 · DOI · Paper page
- Ge, 2011, Requirement of the NF-κB pathway for induction of Wnt-5A by interleukin-1β in condylar chondrocytes of the temporomandibular joint: functional crosstalk between the Wnt-5A and NF-κB signaling pathways, Osteoarthritis Cartilage, 19, 111, 10.1016/j.joca.2010.10.016 · DOI
- Glass, 2012, Inflammation and lipid signaling in the etiology of insulin resistance, Cell Metab, 15, 635, 10.1016/j.cmet.2012.04.001 · DOI · Paper page
- Nomachi, 2008, Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A, J Biol Chem, 283, 27973, 10.1074/jbc.M802325200 · DOI · Paper page
- Oishi, 2003, The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway, Genes Cells, 8, 645, 10.1046/j.1365-2443.2003.00662.x · DOI · Paper page
- Yamanaka, 2002, JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates, EMBO Rep, 3, 69, 10.1093/embo-reports/kvf008 · DOI · Paper page
- Schambony, 2007, Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway, Dev Cell, 12, 779, 10.1016/j.devcel.2007.02.016 · DOI · Paper page
- Han, 2013, JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation, Science, 339, 218, 10.1126/science.1227568 · DOI · Paper page
- Permana, 2006, Macrophage-secreted factors induce adipocyte inflammation and insulin resistance, Biochem Biophys Res Commun, 341, 507, 10.1016/j.bbrc.2006.01.012 · DOI · Paper page
- Prats-Puig, 2014, Balanced duo of anti-inflammatory SFRP5 and proinflammatory WNT5A in children, Pediatr Res, 75, 793, 10.1038/pr.2014.29 · DOI
- Catalán, 2014, Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation, J Clin Endocrinol Metab, 99, E1407, 10.1210/jc.2014-1191 · DOI
- Masckauchán, 2006, Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2, Mol Biol Cell, 17, 5163, 10.1091/mbc.e06-04-0320 · DOI · Paper page
- Bilkovski, 2010, Role of WNT-5a in the determination of human mesenchymal stem cells into preadipocytes, J Biol Chem, 285, 6170, 10.1074/jbc.M109.054338 · DOI
- Kim, 2010, Wnt5a induces endothelial inflammation via beta-catenin-independent signaling, J Immunol, 185, 1274, 10.4049/jimmunol.1000181 · DOI · Paper page
- Oderup, 2013, Canonical and noncanonical Wnt proteins program dendritic cell responses for tolerance, J Immunol, 190, 6126, 10.4049/jimmunol.1203002 · DOI
- Valencia, 2011, Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features, J Immunol, 187, 4129, 10.4049/jimmunol.1101243 · DOI
- Bergenfelz, 2012, Wnt5a induces a tolerogenic phenotype of macrophages in sepsis and breast cancer patients, J Immunol, 188, 5448, 10.4049/jimmunol.1103378 · DOI
- Schaale, 2011, Wnt signaling in macrophages: augmenting and inhibiting mycobacteria-induced inflammatory responses, Eur J Cell Biol, 90, 553, 10.1016/j.ejcb.2010.11.004 · DOI · Paper page
- Malhotra, 2009, Canonical Wnt pathway signaling suppresses VCAM-1 expression by marrow stromal and hematopoietic cells, Exp Hematol, 37, 19, 10.1016/j.exphem.2008.08.008 · DOI
- Manicassamy, 2010, Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine, Science, 329, 849, 10.1126/science.1188510 · DOI · Paper page
- Neumann, 2010, Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages, FASEB J, 24, 4599, 10.1096/fj.10-160994 · DOI
- Ouchi, 2010, Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity, Science, 329, 454, 10.1126/science.1188280 · DOI · Paper page
- Li, 2008, Sfrp5 coordinates foregut specification and morphogenesis by antagonizing both canonical and noncanonical Wnt11 signaling, Genes Dev, 22, 3050, 10.1101/gad.1687308 · DOI · Paper page
- Mori, 2012, Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition, J Clin Invest, 122, 2405, 10.1172/JCI63604 · DOI · Paper page
- Wada, 2013, Selective modulation of Wnt ligands and their receptors in adipose tissue by chronic hyperadiponectinemia, PLoS ONE, 8, e67712, 10.1371/journal.pone.0067712 · DOI
- Nishizuka, 2008, Wnt4 and Wnt5a promote adipocyte differentiation, FEBS Lett, 582, 3201, 10.1016/j.febslet.2008.08.011 · DOI
- van Tienen, 2009, Wnt5b stimulates adipogenesis by activating PPARgamma, and inhibiting the beta-catenin dependent Wnt signaling pathway together with Wnt5a, Biochem Biophys Res Commun, 387, 207, 10.1016/j.bbrc.2009.07.004 · DOI
- Laudes, 2011, Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes, J Mol Endocrinol, 46, R65
- Takada, 2007, A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation, Nat Cell Biol, 9, 1273, 10.1038/ncb1647 · DOI · Paper page
- Ishitani, 2003, The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling, Mol Cell Biol, 23, 131, 10.1128/MCB.23.1.131-139.2003 · DOI · Paper page
- Di Gregorio, 2004, Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity, Am J Physiol Endocrinol Metab, 287, E182, 10.1152/ajpendo.00189.2003 · DOI · Paper page
- Klover, 2005, Interleukin-6 depletion selectively improves hepatic insulin action in obesity, Endocrinology, 146, 3417, 10.1210/en.2004-1468 · DOI · Paper page
- Bastard, 2002, Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro, J Clin Endocrinol Metab, 87, 2084, 10.1210/jcem.87.5.8450 · DOI · Paper page
- Vozarova, 2001, Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion, Obes Res, 9, 414, 10.1038/oby.2001.54 · DOI · Paper page
- Pradhan, 2001, C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus, JAMA, 286, 327, 10.1001/jama.286.3.327 · DOI · Paper page
- Bashan, 2007, Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity, Endocrinology, 148, 2955, 10.1210/en.2006-1369 · DOI
- Cartier, 2008, Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men, J Clin Endocrinol Metab, 93, 1931, 10.1210/jc.2007-2191 · DOI · Paper page
- Park, 2005, Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6, Diabetes Res Clin Pract, 69, 29, 10.1016/j.diabres.2004.11.007 · DOI · Paper page
Cited by
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
Zhang, M., Liu, Q., Meng, H., Duan, H., Liu, X., Wu, J., Gao, F., Wang, S., Tan, R., & Yuan, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01688-x · Cited by 712
Fuster, J. J., Ouchi, N., Gokce, N., & Walsh, K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306885 · Cited by 664
Self-citationFoundations of Immunometabolism and Implications for Metabolic Health and Disease
Hotamisligil, G. S. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.009 · Cited by 505
Signaling pathways in obesity: mechanisms and therapeutic interventions
Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01149-x · Cited by 410
Metadata
- Authors
- Fuster, J. J., Zuriaga, M. A., Ngo, D. T.-M., Farb, M. G., Aprahamian, T., Yamaguchi, T. P., Gokce, N., & Walsh, K.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-10-28
- Volume
- 64
- Issue
- 4
- Pages
- 1235-1248
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2165379056
- Cited by
- 162
- References
- 15
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- American Heart Association (12POST11780028)
- National Institutes of Health (AG034972, HL081587, HL084213, HL1145675, HL116591, HL120160, HL68758, P30DK046200, UL1RR025771)
- Ramon Areces Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.